Nanobac Financial Statements From 2010 to 2025
| NNBP Stock | USD 0.0001 0.00 0.00% |
Check Nanobac Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nanobac Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Nanobac financial statements analysis is a perfect complement when working with Nanobac Pharmaceuticals Valuation or Volatility modules.
Nanobac |
Nanobac Pharmaceuticals Incorporated Company Return On Asset Analysis
Nanobac Pharmaceuticals' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Nanobac Pharmaceuticals Return On Asset | -0.37 |
Most of Nanobac Pharmaceuticals' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nanobac Pharmaceuticals Incorporated is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Nanobac Pharmaceuticals Incorporated has a Return On Asset of -0.3684. This is 95.79% lower than that of the Biotechnology sector and 98.44% lower than that of the Health Care industry. The return on asset for all United States stocks is 163.14% higher than that of the company.
Nanobac Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nanobac Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Nanobac Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nanobac Pharmaceuticals competition to find correlations between indicators driving Nanobac Pharmaceuticals's intrinsic value. More Info.Nanobac Pharmaceuticals Incorporated is rated below average in return on asset category among its peers. It is rated below average in operating margin category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Nanobac Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Nanobac Pharmaceuticals Financial Statements
Nanobac Pharmaceuticals shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Nanobac Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Nanobac Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Nanobac Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Nanobac Pharmaceuticals, Incorporated discovers and develops products and services to improve human health through the detection and treatment of calcifying nanoparticles . The company was founded in 1994 and is based in Tampa, Florida. Nanobac Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.
Additional Tools for Nanobac Stock Analysis
When running Nanobac Pharmaceuticals' price analysis, check to measure Nanobac Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobac Pharmaceuticals is operating at the current time. Most of Nanobac Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Nanobac Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobac Pharmaceuticals' price. Additionally, you may evaluate how the addition of Nanobac Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.